Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What i meant was they were in ariad last oct when it was in 2's. Manager may have knack for deep value investments. At over 70% healthcare they prob did over 35-40% last in net returns.
Maybe. If you look at their portfolio i am sure they pull in excess of 35% last or more
Camber capital mgmt took at 5.97% stake in amarin and disclosed it today. 10.3m shares in total. Same folks who go into Ariadne a few months back. I am also showing jennison completely out and franklin now with 1m shares only. Institutional holders have declined from 3rd qtr. camber has 77% of their holdings in healthcare stocks and is valued approx $1b in total holdings. Basically amarin is a 2-3% position in the fund. Not sure if they are the ones playing those calls either. In the next week or so it will be interesting to see who's in and who's out with the 13g filings.
Sales, sales, sales, sales.....that's all we need....if they just spent more money from the beginning on promoting and selling or just even partnering instead of doing it themselves....this anchor drama would be a non issue as we would have sales revenue. This flat line performance with a clearly superior drug is troubling. I recommend they focus on more sales or get someone to help them.
I am long time bull and still believe they can do it but this shooting for the fence on anchor like it will be a life changing event for them is tiresome. Even if anchor is approved my next worry is can you ramp up sales anyway from here....you never expect sales...no such thing...and have to work for each one.
My point keep selling and take market share. More you take the more the big boys love you and the higher your sp will be. If anchor comes then good, now you can sell to more people and walk the competition.
I think the 8k is just worst case scenario planning or sand bagging. I don't think they know about what fda is planning and if they did they would obviously be trading or planning on inside information which is not legal. With all that has happened to them, I would say they are being more conservative in their strategic plans and doing their best tie down management team to execute. Original incentive was done with joe z still in control, this has possibly now included jts input which could probably be more conservative due to his finance background. There is a big difference in how a sales guy projects a goal (obviously and usually very optimistic) and a finance guy projects is my point.
Let's keep pushing and Glta.....short % drop is nice....thinking a lot of folks including those who are not long have moved on to other things they can short just like many left being long and moved on. A partner is still the best solution IMHO. Anchor or what not, if they boost sales they will be golden. All else is gravy. If gsk can sell $1b of lovaza without an anchor type indication then we can with a much better drug. I don't believe they can do it on their own and need a lot more help. A drug can't always sell itself without people knowing about it. If they got reduce it with positive cvd outcome everyone would know about it is my point.
Finally closed exactly at its 50 day moving avg 2.23, slow and steady grind
Correct, with all the volume left and right since adcom, anything above 5% beneficial interest needs to be reported. So far nothing. We need to wait until end of jan, beg. Of feb to see new 13f filings ending dec 2013. It will include adcom fiasco time and dec 21st spa delay stock moves. That would be a true tell for me to see who's still in and who's out.
I agree on short covering today but I also see a lot of sellers allowing folks to cover. Stock has a catalyst and I am hopeful it will turn out well for them by the 15th.
We need a partner. Just cause we may have anchor and better science, drug, won't change if we don't sell enough. Glta
Talk about price pegging.....no movement either way....happy holidays to all on this board the excellent commentary. Hopefully 2014 bodes well on the news front.
He should take some cash and start executing those options to buy and hold at these levels....better pay long term cap gains than ordinary income in my opinion.
Jesus N...the triangle trader just went long the stock yesterday or today at 1.65. His main focus was on how it helped him personally with his trigs. He did exit the stock and called "drama" a month or so before adcom. He's a big swing trader according to his trade reports but one never knows. For now, it's kind of nice to see him back in a sense as he's been out for some time.
Same thing I was thinking.....with all this drama you would expect some coverage and so far...nada except negative ones.
Agreed all the way
Agreed but doesnt mean amrn is not in 10% camp...point being there could always be surprises...nature of the asset class...works both on up and downside situations
Agreed....everyone is entitled to their opinion which is a whole lot better than not even having an opinion...again with 95% of sentiment either being negative or in surrender format....it would not be surprising to see something positive come out. How many bios have dropped significantly only to return from the ashes....especially those without risk related concerns to their drug or treatment.
Jcp CEO bought over 100k shares at the market to support his company....Joe bought 50.7k only....that's almost a $1m vs. $80k...management needs to buy much more than this. On fda news, might as well try higher up first than with the same folks responsible for the turn in events. Issue I worry about now is they may have ticked them off by approaching their bosses per se by going above them. It was worth a try.
Page 5 of 14 2nd paragraph hits it close to home with their stacking attempt to get their desired outcome from a panel...crazy. Excellent resource thank you
Holding period is as of Sept 30th end....adcom was oct so in reality won't know until February 2014 I guess who dumped and who bought. Not showing any one off holdings updates as of Oct but will keep watching. Judging from volume on October 17th would not be surprised if a lot of institutional holders exited.
Awesome thanks...
I would think there would be a bit more of a runup into data release with this one but so far struggling to break .30. Been in for a while and run to .36 was great until offering
I thought data coming out soon? N size a bit small but results are impressive. Any estimated timeframe for data?
"We" people who make up this board that are long amarin shares or simply support Amarins success. Please go to their website or google amarin earnings and read last qtr earnings report so you can make your own assumptions or product growth. So far vascepa script growth slow but trending up.
Hopefully we get some form 4s this week from mgmt...increase in short interest is awesome...more for a squeeze in the event something they don't expect happens...stock is already down huge and trading basically for nothing. Product will ramp up overtime...for shorts it's a gain of 100% or a loss that could be massively painful.
Agreed 100%
I agree then top 4 in mgmt should cut salaries in support of reducing costs then. There have been talks for years and they should have a right to buy some shares here due to valuation if nothing serious is on hand. Bp will buy only if they see sales growth. They may not if they see vascepa as a threat to statin therapy. We need a non statin related company to buy into it with a large enough sales force to complement.
Now all we need is a show of force on the buying end from mgmt. I need to see some serious doe thrown at the stock this week. Very curious as to know what new institutional holdings are.
Better rescind that too only fair...
From the cc call....
With respect to the population studies in the ANCHOR trial, the FDA also appears to have entered into an SPA with another company for their drug after the ACCORD and AIM-HIGH data were publicly presented suggesting that these study results were not viewed by the FDA as substantially new scientific information at that time. And we are not aware of any subsequent data which should have changed this perspective.
Is this really azn-epanova? Are they basically saying if you rescind ours then rescind theirs?
No thank you for putting him in his place. Sometimes some people can be clueless with their comments....what I dislike most is he doesn't have a position in this company.....if you write hit or bullish pieces...own it...either way. My family has similar health issues and I believe it will work.
Haha I would agree....a whole article dedicated to him...
If amrn gets anchor approval....I want someone on SA to write a great hit piece article referencing him....no need to talk about a stock...just qtr hindsight commentaries.
My take...thank you mgmt for standing up to this crap....had they remotely showed this kind of vigor during adcom cc I think the stock would be in the 3s - 4s and not down here. Mgmt has to instill confidence and I still stand by my recommendation for them to do an open market buy for large amounts of stock. If they believe....they will and should buy their own stock. If they buy, I will buy more.
Qtr just got cursed by a poster named Gary....funniest comeback and comment I've seen posted on those useless articles qtr been writing.
Amen....I would love mgmt to throw a boulder instead
Anyone know who the other company with spa they were talking about? Was it the fino drug just approved 2 days after adcom?
Otc pkatform down i think
Interesting.....I would still want and expect a clear explanation of where we are and where we are going from mgmt. I want to see them buy $1m shares each with their own money not an option execution. That will give me confidence. Having the new combo approved is fine but we really do need someone to help them sell it anyway.....sales are too slow IMHO for marine.
Our combo pill or is there another one we are getting slapped with?
I can actually count the number of folks who are actually positive about amrn and it's prospects. Even ws is neutral to negative. Reminds me of Bank of America at $4, citi under $1, nflx in $50s. Not giving any premonitions but when everyone is on the same side (negative) could be dangerous. This works both ways on the up and on the down. Someone is picking up those shares carefully, they don't just disappear into thin air. It would be interesting to see new institutional holdings for sept end. Mgmt cc tomorrow is critical and I hope they have a battle plan in place. Jmho.
Approving this is a real slap in the face.....if the voting question were similar, we would have had a different outcome. Mgmt better speak clearly about direction and they better speak with some gut in them.
Excellent, just what I was looking for. Poor coverage on this stock. Thank you for your input.